Expedited Development Enabled by RMAT and Breakthrough Therapy StatusClinical Trial Initiation in 2026, FDA Approval Target ...

Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for TNKase® ...

Canada: The study indicates that botulinum toxin ( BTX) is a safe and effective adjunct treatment for refractory ischemic ...

Health Canada recently approved the injection treatment for acute ischemic stroke in adults, the first stroke medicine ...

Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke severity, prior to ...

Researchers have developed a novel "theragnostic" approach for ischemic stroke using extracellular vesicles derived from human exfoliated deciduous teeth stem cells (SHED-EVs). Engineered with quantum ...

The existing clinical data supporting safety and efficacy of CardiAMP Cell Therapy for HFrEF is subject to ongoing regulatory discussions in Japan and the United States. The compilation includes data ...

With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important ...

Severe stomach pain can hide a silent threat that even seasoned doctors struggle to spot in time. One of the most dangerous ...

Healios KK ( ($JP:4593) ) has issued an update. Healios KK announced its development policy for HLCM051, prioritizing its use as a treatment for ...

The anticoagulant reversal drug Andexxa was voluntarily pulled from the US market after failing to secure full FDA approval ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...